Question 1

What are the most cited papers from BBB Therapeutics (Netherlands)?

Accepted Answer

The most cited paper from BBB Therapeutics (Netherlands) is "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens" (Matthew M. Gubin et al., 2014), with 2,015 citations. Next come "Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration" (116) and "Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo" (91).

Question 2

Which research topics does BBB Therapeutics (Netherlands) publish most on?

Accepted Answer

By volume in 2022-now: RNA Interference and Gene Delivery, Influenza Virus Research Studies, Immune Response and Inflammation and Extracellular vesicles in disease.

Question 3

Which fields of science does BBB Therapeutics (Netherlands) work in?

Accepted Answer

In all years, 39% of research at BBB Therapeutics (Netherlands) is in Life Sciences, 34% in Health Sciences. Its largest fields are Medicine (34%), Biochemistry, Genetics and Molecular Biology (25%), Materials Science (14%). It does 1.4× the world's share of Life Sciences.

Question 4

Is BBB Therapeutics (Netherlands)'s research output growing?

Accepted Answer

Output in 2022-2025 was 11% higher than in 2018-2021.